Quarterly report pursuant to Section 13 or 15(d)

Condensed Consolidated Statements of Cash Flows

v3.22.0.1
Condensed Consolidated Statements of Cash Flows - USD ($)
3 Months Ended
Dec. 31, 2021
Dec. 31, 2020
Cash flows from operating activities    
Net loss $ (7,728,816) $ (4,066,431)
Adjustments to reconcile net loss to net cash used in operating activities    
Stock-based compensation 793,204 1,176,585
Change in fair value of warrant liabilities 0 (630,112)
Depreciation and amortization 181,490 68,117
Loss on marketable securities 30 14,970
Loss on disposal of fixed asset 7,595 0
Equity in losses on equity method investment 415,744 25,412
Non-cash expense from right-of-use assets 103,599 0
Changes in operating assets and liabilities    
Prepaid insurance, other prepaid expenses and current assets 877,266 (25,132)
Long-term prepaid insurance 0 48,417
Security deposit 0 (253,565)
Other long-term assets 160,423 0
Accounts payable (680,142) (327,087)
Accrued expenses and other current liabilities 665,134 187,965
Operating lease liability (63,973) 0
Net cash used in operating activities (5,268,446) (3,780,861)
Cash flows from investing activities    
Purchase of laboratory and office equipment (123,876) (193,571)
Purchase of marketable securities (14,986,818) (15,003,771)
Sale of marketable securities 14,986,788 14,988,801
Net cash used in investing activities (123,906) (208,541)
Cash flows from financing activities    
Principal payment of financed insurance (148,385) (138,557)
Principal payment of finance lease liability (26,632) 0
Proceeds from exercise of stock options 42 112,446
Net cash used in financing activities (174,975) (26,111)
Net decrease in cash and cash equivalents (5,567,327) (4,015,513)
Cash and cash equivalents, beginning of period 52,893,387 31,992,283
Cash and cash equivalents, end of period 47,326,060 27,976,770
Supplemental disclosure of cash flow information:    
Cash paid for interest 0 10,400
Cash paid for income taxes 0 0
Non-cash investing and financing activities:    
Purchases of laboratory and office equipment in accounts payable $ 65,970 $ 0